Maximizing prices, contracting, and securing reimbursement status are important factors for health care companies seeking to ensure that they achieve a high return on investment. This return must be viable under volatile conditions such as regulatory uncertainty, stagnant R&D, and cost-containment efforts of health care payers.
MME provides detailed analysis of the key issues and of the market environment which together make up the pricing and reimbursement evaluation landscape. This information gives customers a detailed understanding of the opportunities to maximize profit through value instead of simply price. Your company will have not only an optimized understanding of a product’s current potential but also a way to extend and enhance future returns.
MME has extensive experience in portfolio evaluation and life-cycle planning with major customer segments, including:
The following are examples of our work in this area: